Culture 6/23/2026
FDA Recalls Blood Pressure Medication: Full List of Lots Included in Chlorthalidone Recall
Over 11,000 bottles of Chlorthalidone Tablets USP, 25 mg, a widely prescribed blood pressure medication, have been recalled by India-based manufacturer Inventia Healthcare Limited due to concerns that the pills may not dissolve properly in patients' bodies. This voluntary recall, distributed in the U.S. by Rising Pharma Holdings Inc. and initiated on June 5, 2026, stems from a 'failed dissolution specifications' test, meaning the active ingredient might not be absorbed as intended, potentially rendering the medication ineffective.
